Ho AL, Dedecjus M, Wirth LJ, Tuttle RM, et al. Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA). J Clin Oncol 2022;40:1870-1878.
PMID: 35192411